EssilorLuxottica披露二季度业绩增长，智能眼镜收入接近翻倍

Nasdaq cuts most of its losses, Dow surges on extended oil slide, solid earnings
Introduction & Market Context
EssilorLuxottica (EPA:EL) presented its second quarter and first half 2026 results on July 28, revealing broad-based revenue growth and margin expansion driven by both its traditional eyewear business and emerging categories including smart glasses and myopia management products. The company reported Q2 revenue growth of 8.7% at constant exchange rates and first-half growth of 9.7%, with adjusted operating margins expanding 80 basis points.
Despite the solid operational performance, the stock closed at $168.65, up just 1.96% on the day, and remains near its 52-week low of $160.60—roughly 48% below its 52-week high of $323.80. The muted market reaction suggests investors remain cautious about valuation or growth sustainability even as the company delivers on its medium-term financial targets.
Quarterly Performance Highlights
As detailed in the company’s financial highlights presentation, EssilorLuxottica delivered consistent acceleration across key metrics in the first half of 2026. The group’s revenue reached €7.69 billion in Q2, representing growth of 8.7% at constant exchange rates and 7.2% at current rates.
The following table shows the company’s revenue growth trajectory for both the quarter and half-year periods, with constant currency growth significantly outpacing reported figures due to foreign exchange headwinds.
Regional performance showed particular strength in Asia-Pacific, which posted 17.0% constant-currency growth in Q2, while all other major regions delivered high-single digit gains. North America grew 7.2%, EMEA advanced 8.0%, and Latin America increased 6.7% at constant exchange rates.
For the full first half, the geographic breakdown demonstrates consistent momentum across all markets, with Asia-Pacific maintaining its leadership position at 13.4% constant-currency growth.
Segment Performance & Strategic Growth Drivers
The company’s Direct to Consumer segment significantly outpaced its Professional Solutions business during the quarter. As shown in the segment breakdown, Direct to Consumer revenue reached €4.24 billion in Q2, growing 11.9% at constant rates, while Professional Solutions generated €3.45 billion with 4.9% growth.
Retail comparable-store sales increased 8.0% in Q2, with both optical and sun banners contributing equally to the performance. The company’s store footprint expanded dramatically during the first half, reaching 19,686 total locations by June 30, up from 17,750 at year-end 2025. The expansion was particularly pronounced in Asia-Pacific, where corporate stores more than doubled to 3,613 from 1,682.
Beyond traditional frames and lenses, EssilorLuxottica highlighted two key growth engines. The company’s myopia management portfolio, anchored by products like Stellest, delivered 24% revenue growth in Q2. Even more dramatically, AI-enabled smart glasses—including the Ray-Ban Meta collaboration—nearly doubled their revenue during the quarter, with management noting improving unit economics as prescription lens penetration increases and manufacturing productivity gains take hold.
Chairman and CEO Francesco Milleri described the company’s evolution "from the best in class in frame and lenses to the pioneer of the wearable category, and now into the eye MedTech and oculomics healthcare leader."
Profitability & Margin Expansion
EssilorLuxottica demonstrated operating leverage throughout the first half, with profitability metrics improving at both the gross and operating levels. The company’s adjusted operating margin expanded to 18.9% at constant exchange rates, representing an 80 basis point improvement over the prior year period.
The comprehensive profit and loss statement reveals the drivers behind margin expansion. While revenue grew 9.7% at constant rates in H1, operating profit advanced 15.0%—significantly faster than the top line. Gross margin held steady at 63.5%, while disciplined expense management allowed operating expenses to grow just 7.6%, well below revenue growth.
CFO Stefano Grassi highlighted several factors supporting margin improvement, including favorable price mix, productivity gains, and net positive tariff impacts of 60 basis points on gross margin in the first half. The company expects additional tariff refunds in the second half, though at lower absolute levels than the prior year.
Net profit reached €1.92 billion for the first half, growing 13.3% at constant exchange rates, with net margin improving 50 basis points to 13.3% on a constant-currency basis.
Financial Position & Cash Generation
Free cash flow emerged as a particular strength in the first half, reaching €1.07 billion—the strongest first-half result in five years and more than €100 million above the prior year period. Grassi characterized this as a standout metric, noting the company’s ability to generate substantial cash while investing heavily in growth initiatives.
The company’s balance sheet showed net debt of €13.39 billion as of June 30, 2026, including €3.91 billion in lease liabilities. The net debt-to-EBITDA ratio stood at 2.0x, within comfortable ranges for a company of EssilorLuxottica’s scale and cash generation profile. Cash and cash equivalents totaled €1.93 billion.
According to the earnings call transcript, the company has maintained dividend payments for 35 consecutive years, underscoring management’s commitment to shareholder returns even while funding expansion in wearables, myopia products, and retail infrastructure.
Strategic Initiatives & Future Pipeline
Looking beyond the current results, EssilorLuxottica outlined several strategic initiatives designed to extend its leadership in both traditional and emerging eyewear categories.
The company announced a strategic partnership with Applied Materials focused on developing new generations of intelligent optical systems. This collaboration, which involves shared patents and co-development work, targets next-generation optical systems for AI and augmented reality wearables, with products expected to reach the market in early 2027.
In the myopia management category, the company is expanding its Stellest product availability in the United States, where adoption remains in early stages but is building momentum through doctor outreach and retail expansion. Management indicated plans for consumer marketing campaigns to accelerate awareness and uptake in the U.S. market, which is now contributing more meaningfully as the category broadens beyond its initial strength in China.
For smart glasses, the company plans to launch a second-generation Nuance Audio product in mid-September 2026, while continuing to scale Ray-Ban Meta and introducing Oakley Meta variants. Management emphasized that EssilorLuxottica remains the exclusive lens manufacturer for Meta’s smart glasses platform, a strategic position as the wearables category continues to develop.
The company also highlighted upcoming product launches for its Varilux lens brand and other core optical products, demonstrating continued innovation in its traditional business even as it pushes into adjacent categories.
Market Disconnect & Forward Outlook
The contrast between EssilorLuxottica’s operational performance and its stock price trajectory presents a notable market puzzle. While the company delivered revenue growth approaching 10% at constant currency, expanded margins, generated record first-half cash flow, and accelerated growth in high-potential categories, shares remain nearly 50% below their 52-week high.
During the earnings call, management expressed confidence in the outlook, noting that July proved to be "a good month" and reiterating the company’s ability to deliver on its financial ambitions and strategic plans. The company expects positive gross margin trajectory in the second half, supported by price mix, scale benefits, and productivity improvements.
Analysts on the call focused heavily on the economics of smart glasses, the sustainability of tariff benefits, and the pace of myopia adoption in the United States. Management’s responses suggested improving unit economics for wearables, potential for additional tariff refunds in H2, and building traction for myopia products through expanded distribution and education efforts.
The company’s evolution from pure-play eyewear manufacturer to a diversified vision care and wearables platform appears to be progressing according to plan, with traditional business resilience providing a foundation for investment in higher-growth categories. Whether the market’s cautious valuation reflects concerns about execution risk in newer categories, uncertainty about the durability of current growth rates, or simply broader market dynamics remains an open question as EssilorLuxottica enters the second half of 2026.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.